ELIQUENT Life Sciences Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 237

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 4

  • Investments
  • 6

ELIQUENT Life Sciences General Information

Description

Provider of compliance and regulatory affairs consulting services intended to serve pharmaceutical, biologics, medical device and diagnostics manufacturers. The company offers reliable systems design, strategy, implementation, health authority enforcement action response as well as remediation services, thereby ensuring safe and reliable access to life-saving healthcare products.

Contact Information

Formerly Known As
Validant
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 150 Sutter Street
  • Suite 75
  • San Francisco, CA 94104
  • United States
+1 (415) 000-0000
Primary Industry
Practice Management (Healthcare)
Other Industries
Consulting Services (B2B)
Other Healthcare Services
Vertical(s)
Corporate Office
  • 150 Sutter Street
  • Suite 75
  • San Francisco, CA 94104
  • United States
+1 (415) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ELIQUENT Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ELIQUENT Life Sciences‘s full profile, request access.

Request a free trial

ELIQUENT Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of compliance and regulatory affairs consulting services intended to serve pharmaceutical, biologics, medical d
Practice Management (Healthcare)
San Francisco, CA
237 As of 2023
00.000
000000000000

000000

ehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
0000000000 00000000
Washington, DC
00 As of 0000
000000000000

000000

r incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nos
00000000 0000000000
Raleigh, NC
0000 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ELIQUENT Life Sciences Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Greenleaf Health Private Equity-Backed Washington, DC 00 000000000000
ProPharma Group Private Equity-Backed Raleigh, NC 0000 000.00 000000000 - 000.00
RQM+ Private Equity-Backed Monroeville, PA 000 00000 000000000 00000
4C Pharma Solutions Corporation Piscataway, NJ 000
Qserve Group Corporation 00
You’re viewing 5 of 25 competitors. Get the full list »

ELIQUENT Life Sciences Executive Team (13)

Name Title Board Seat
Tim Dietlin Chief Executive Officer
Brian Burns President
Steve Purtell Chief Financial Officer
Barbara Clendenen Chief Business Development Officer
Martyn Edney Chief Human Resources Officer
You’re viewing 5 of 13 executive team members. Get the full list »

ELIQUENT Life Sciences Board Members (4)

Name Representing Role Since
0000000 00000000 GHO Capital Board Member 000 0000
0000000 000000 GHO Capital Board Member 000 0000
000000 00000000 GHO Capital Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

ELIQUENT Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ELIQUENT Life Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ELIQUENT Life Sciences‘s full profile, request access.

Request a free trial

ELIQUENT Life Sciences Investments (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
RApport Global Strategic Services 18-Jan-2024 0000000000 Consulting Services (B2B) 000 00000
Clinical Outcome Solutions 20-May-2021 0000000000 Consulting Services (B2B) 0000000 0
Greenleaf Health 19-Apr-2021 0000000000 Consulting Services (B2B) 0000000 0
Oriel Stat A Matrix 31-Dec-2020 0000000000 Consulting Services (B2B) 00000 000
IDEC (Japan) 24-Nov-2020 Buyout/LBO Practice Management (Healthcare) 00000 000
You’re viewing 5 of 6 investments. Get the full list »

ELIQUENT Life Sciences Subsidiaries (6)

Company Name Industry Location Founded
DataRevive Consulting Services (B2B) Rockville, MD 2016
Clinical Outcome Solutions Consulting Services (B2B) Tucson, AZ 0000
Greenleaf Health Consulting Services (B2B) Washington, DC 0000
IDEC (Japan) Practice Management (Healthcare) Tokyo, Japan 0000
RApport Global Strategic Services Consulting Services (B2B) Camberley, United Kingdom 0000
You’re viewing 5 of 6 subsidiaries. Get the full list »

ELIQUENT Life Sciences FAQs

  • When was ELIQUENT Life Sciences founded?

    ELIQUENT Life Sciences was founded in 2005.

  • Who is the founder of ELIQUENT Life Sciences?

    Brian Healy is the founder of ELIQUENT Life Sciences.

  • Who is the CEO of ELIQUENT Life Sciences?

    Tim Dietlin is the CEO of ELIQUENT Life Sciences.

  • Where is ELIQUENT Life Sciences headquartered?

    ELIQUENT Life Sciences is headquartered in San Francisco, CA.

  • What is the size of ELIQUENT Life Sciences?

    ELIQUENT Life Sciences has 237 total employees.

  • What industry is ELIQUENT Life Sciences in?

    ELIQUENT Life Sciences’s primary industry is Practice Management (Healthcare).

  • Is ELIQUENT Life Sciences a private or public company?

    ELIQUENT Life Sciences is a Private company.

  • What is ELIQUENT Life Sciences’s current revenue?

    The current revenue for ELIQUENT Life Sciences is 000000.

  • How much funding has ELIQUENT Life Sciences raised over time?

    ELIQUENT Life Sciences has raised $2.28M.

  • Who are ELIQUENT Life Sciences’s investors?

    Goldman Sachs Asset Management, Los Angeles County Employees' Retirement Association, and GHO Capital have invested in ELIQUENT Life Sciences.

  • Who are ELIQUENT Life Sciences’s competitors?

    Greenleaf Health, ProPharma Group, RQM+, 4C Pharma Solutions, and Qserve Group are some of the 25 competitors of ELIQUENT Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »